GlassScriptPhysician profile
Douglas M Galen
NPI 1417016924
$5,823.60
in general payments reported to CMS, 2019-2025
12 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2020: $510 · 2021: $89.10 · 2022: $3,053 · 2023: $1,174 · 2024: $71.02 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $720 · Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $720.00 |
| Food and Beverage | $706.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih INC. | $3,000.00 | 2022 | |
| Biohorizons Implant Systems INC. | $993.76 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| Dentsply LLC | $720.00 | 2023 | |
| Vatech America, INC. | $415.84 | 2019 | |
| Nobel Biocare USA | $199.97 | 2019-2023 | Nobelactive |
| Ormco Corporation | $124.74 | 2023 | |
| Geistlich Pharma, North America, INC. | $117.86 | 2023 | Bio-Materials |
| Salvin Dental Specialties, INC. | $99.15 | 2019 | |
| Henry Schein, INC. | $83.09 | 2025 | Nuoss, Allooss Allograft Putty, Ace Surgical Supply |
| Straumann USA LLC | $34.82 | 2019 | |
| Ace Surgical Supply Co., INC. | $17.99 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.38 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Galen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.